• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

Anticorps Polyclonal de lapin anti-NPFFR1

NPFFR1 Polyclonal Antibody for WB, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

N° de cat : 23415-1-PBS

Synonymes

G protein coupled receptor 147, GPR147, neuropeptide FF receptor 1, OT7T022

Galerie de données de validation

Filter:
  • Western Blot (WB) analysis of various lysates using NPFFR1 Polyclonal antibody (23415-1-AP)

    WB analysis using 23415-1-AP (same clone as 23415-1-PBS)

    Various lysates were subjected to SDS PAGE followed by western blot with 23415-1-AP (NPFFR1 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 23415-1-PBS in a different storage buffer formulation.

Informations sur le produit

23415-1-PBS cible NPFFR1 dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat

Réactivité Humain, rat
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène NPFFR1 Protéine recombinante Ag20057
Nom complet neuropeptide FF receptor 1
Masse moléculaire calculée 430 aa, 48 kDa
Poids moléculaire observé48-50 kDa
Numéro d’acquisition GenBankBC131580
Symbole du gène NPFFR1
Identification du gène (NCBI) 64106
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purifié par affinité contre l'antigène
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

NPFFR1 (Neuropeptide FF Receptor 1) is primarily focused on its role in various physiological and pathological processes. NPFFR1 is involved in modulating the effects of opioids, including their analgesic properties and side effects. This interaction has led to research into the potential use of NPFFR1 ligands to enhance opioid efficacy and reduce adverse effects (PMID: 32673481). Research suggests that NPFFR1 may have neuroprotective effects, particularly in the context of stroke recovery. It may promote neuronal survival, axonal growth, and reduce inflammation (PMID: 39519132).

{{ptg:RelatedPrimaryAntibodies}}